PUBLICATIONS · 32909665
Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2020 Nov
- First author
- Cohen G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Pediatr Blood Cancer. 2020 Nov;67(11):e28418. doi: 10.1002/pbc.28418.
- note
- Source null
- related pmid
- 32798269
- relationship
- Comment in
Authors and identifiers
- name
- Cohen G
- type
- Author
- name
- Cooper S
- type
- Author
- name
- Sison EA
- type
- Author
- name
- Annesley C
- type
- Author
- name
- Bhuiyan M
- type
- Author
- name
- Brown P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Cohen G
- type
- Author
- name
- Cooper S
- type
- Author
- name
- Sison EA
- type
- Author
- name
- Annesley C
- type
- Author
- name
- Bhuiyan M
- type
- Author
- name
- Brown P
- type
- Author
- bibliography ids
- nci-bib-6b684fa5c606cdbbed2bd22d
- book metadata
- content sha256
- a2ee83125ed92fc5dfedb82d8c59b8fd46231f0e3c513def4ba13e2cfaeab892
- document type
- citation
- dois
- 10.1002/pbc.28360
- electronic publication date
- display
- 2020 Sep 10
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32909665
- immutable id
- pubmed:32909665@a2ee83125ed92fc5dfedb82d8c59b8fd46231f0e3c513def4ba13e2cfaeab892
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 11
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- e28360
- volume
- 67
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Pediatr Blood Cancer. 2020 Nov;67(11):e28418. doi: 10.1002/pbc.28418.
- note
- Source null
- related pmid
- 32798269
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 32909665
- provenance
- batch id
- 9bca82d1bba2b27adc79
- provider
- NCBI PubMed ESummary
- record sha256
- 294457b88bc09fa9b593a86bd50a4b5fc2a01d13dd9a9917980650d82ac99da8
- response sha256
- c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
- retrieved at
- 2026-09-09T23:47:56.131551+00:00
- publication date
- display
- 2020 Nov
- precision
- month
- year
- 2020
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity.
Preserved source evidence · Not medical advice
Triangle